646
Views & Citations10
Likes & Shares
Pulmonary
fibrosis is commonly characterized by inflammation of the alveolar wall,
leading to derangement of normal alveolar architecture, and interstitial as
well as intra-alveolar fibrosis. The eosinophil is a major source for several
of these key pro-fibro genic cytokines during the early stages of fibrosis. The
percentages of eosinophil in peripheral blood and Bronchoalveolar lavage fluid
are essential parts of the evaluation. This review will focus on the recent
findings, which suggest novel potential roles for the eosinophil in the
pathogenesis of pulmonary fibrosis.
Keywords: Eosinophilia, Cytokines, Interleukin, TPE
INTRODUCTION
Pulmonary fibrosis, meaning scarring in the
lung tissue, is an umbrella term for more than 200 different lung diseases that
all look very much alike. In pulmonary fibrosis, the scar tissue builds up in
the walls of the air sacs of the lungs, and eventually the scar tissue makes it
hard for oxygen to get into the blood. Low oxygen levels (and the stiff scar
tissue itself) can cause to feel short of breath, particularly when walking and
exercising. The most common symptoms of pulmonary fibrosis are cough and
shortness of breath. Symptoms may be mild or even absent early in the disease
process. As the lungs develop more scar tissue, symptoms worsen. One third of
patients suffering from tropical pulmonary eosinophilia develop fibrosis of
lungs.
DESCRIPTION OF CASE
A male aged about 65 years presented to the
Sanaria Lymphology Clinic and Research Center with complaints of dry, hacking,
nonproductive cough, which was frequently paroxysmal and nocturnal. Asthma-like
attacks were associated with breathlessness and wheezing. Other symptoms
included weight loss, fatigue, and malaise. Dyspnea on exertion was uncommon.
Chest findings were minimal. Rhonchi, crepitation (especially over the mid zones
and bases) and wheezing could be auscultated. The absolute eosinophil count was
4,500/µL (reference value<400/µL). The serum immunoglobulin E level was 1400
units/mL (reference value for adults<158 IU/ml). The serum OG4C3
test for detection of circulating adult filarial antigen was moderately
positive, i.e., 512 A.U (antigen units). The negative value is less than 128
A.U. The biochemical parameters of blood were within normal limits and fecal
examination for intestinal parasites found negative.
Photomicrograph shows a combination of air
space filling and interstitial thickening in a patient with chronic
eosinophilic pneumonia. The air space exudate is a combination of histiocytes
and eosinophils.
Images were obtained from the patient with
progressive dyspnea over one month; acute eosinophilic pneumonia was diagnosed
based on the clinical presentation and Bronchoalveolar lavage showing 51%
eosinophils and response to therapy.
The chest radiograph finding includes
increased Broncho-alveolar markings, diffuse interstitial lesions and mottled
opacities in the lower lung fields. Bronchoalveolar lavage showed presence of
eosinophils and response to therapy (Figures
1 and 2).
Pulmonary function tests (PFTs) typically
demonstrated a predominantly restrictive pattern together with mild to moderate
airway obstruction.
A Broncho alveolar lavage (BAL) eosinophil
count was done. It was found to be 48% (normal<30%).
The photomicrograph of lungs tissue of the
patient revealed acute eosinophilic pneumonia with air space exudate and
alveolar septal thickening (Figure 3).
DISCUSSION
Tropical pulmonary eosinophilia (TPE) is a
clinical manifestation of lymphatic filariasis, a parasitic infection caused by
filarial parasite Wuchereria bancrofti [1].
It is caused by an immune hyper-responsiveness to microfilariae trapped in the
lungs. TPE is more common in individuals from the Indian subcontinent and
occurs four to seven times more frequently in males than in females. There were
an ongoing eosinophil interstitial infiltration and increasing pulmonary
fibrosis. No microfilaria fragments identified in biopsied lung. The cardinal
laboratory finding in TPE is blood eosinophilia, usually above 3000/µL [2]. The
patient’s absolute eosinophil count estimated every week was between 3000 and
4500/µL. An elevation in serum immunoglobulin E level is frequently observed;
often above 1000 units/mL [3]. The diagnosis can be confirmed by marked
elevations in filarial circulating antigen titers (OG4C3)
[4,5]. Microfilariae are generally not detectable in peripheral blood. The
chest radiograph findings included increased bronchoalveolar markings, diffuse
interstitial lesions and mottled opacities (usually most prominent in the lower
lung fields. Pulmonary symptoms (cough and breathlessness) are present in 25%
of patients suffering from eosinophilia.
Pulmonary function tests (PFTs) typically
demonstrate a predominantly restrictive pattern together with mild to moderate
airway obstruction [6]. Pulmonary involvements are common in tropical
eosinophilia and may result from eosinophilic infiltration of the lung with
subsequent fibrosis, although the imaging studies in TPE can mimic miliary
tuberculosis [7]. The presence of marked eosinophilia in TPE is an important
distinguishing feature. Standard treatment consists of diethyl carbamazine
(DEC) given at 6 mg/kg/day in three doses for 12 to 21 days [8]. DEC is active
against both the microfilariae and adult worms, and DEC therapy is associated
with a dramatic and rapid improvement in signs and symptoms in most cases. The
restrictive and obstructive defects typically return toward normal if DEC is
administered in the first few years of disease, although a low-grade
eosinophilic alveolitis may persist. If DEC therapy is delayed, progressive
interstitial fibrosis and irreversible impairment in pulmonary function can
occur. Corticosteroid therapy has been used as adjunctive therapy to reduce
inflammation in the acute setting but is not definitive therapy for TPE.
Relapses occur in up to 20% of patients within the first five years of DEC
therapy and are treated with a repeat course of the same treatment regimen.
Other agents used in the treatment of
lymphatic filariasis, included oxycycline (which has efficacy against adult
filarial worms via its action on their Wolbachia endosymbionts. Ivermectin (a
rapid microfilaricide without efficacy on adult worms) and albendazole (which
affects only adult worms) are also used [9]. Bronchospasm can generally be
managed with bronchodilators, although short-term corticosteroids may be
necessary in severe cases. Interleukin 5 (IL5), known as eosinophil
differentiation factor (EDF), is a lineage-specific cytokine for
eosinophilpoiesis [10].
CONCLUSION
Early recognition of an eosinophilic lung
disease is crucial because initiation of proper treatment can often
substantively alter the disease course and diminish morbidity and mortality.
Ultimately, it is the combination of radiologic findings and both clinical and
pathologic information that leads to the most accurate diagnosis.
LEARNING POINTS
-
Patients belonging to tropical zone and
suffering from eosinophilia are prone to pulmonary fibrosis.
-
Early diagnosis and treatment of TPE
prevent future disability and fibrosis of lungs.
CONTRIBUTOR
The author prepared the manuscript, provided
the clinical data and images, conceived the case study, reviewed the literature
and drafted the manuscript.
COMPETING INTERESTS
None declared.
PATIENT CONSENT
Obtained.
1. World Health Organization Bulletin (2015).
2. Ottesen EA, Nutman T B (1992) Tropical Pulmonary
Eosinophilia. Ann Rev Med 43: 417-424.
3. World Health Organization (2017) Lymphatic
filariasis.
4. Panda DK, Mohapatra DP, Mohapatra M (2014) The
complications of surgical treatment of Grade IV filarial lower limb lymphedema.
Austin J Trauma Treat 3.
5. Panda DK (2019) Medical therapy, a better alternative
to micro lymphatic-venous anastomosis in advanced lymphoedema of the leg:
Review of some cases. J Clin Diagn Res 13: PR01-PR02.
6. National Institute for Occupational Safety and
Health (2011) Spirometry.
7. Ray S, Kundu S, Goswami M, Maitra S (2012) Tropical
pulmonary eosinophilia misdiagnosed as miliary tuberculosis: A case report and
literature review. Parasitol Int 61: 381-384.
8. Randev S, Kumar P, Dhillon P, Jindal G, Guglani V (2018)
Tropical pulmonary eosinophilia masquerading as asthma in a 5-year-old girl.
Paediatr Int Child Health 38: 231-234.
9. Durbin K (2019) Doxyxycline. Available online at https://www.drugs.com/doxycycline.html
10. Campbell HD, Tucker WQ, Hort Y, Martinson ME, Mayo G,
et al. (1987) Molecular cloning, nucleotide sequence and expression of the gene
encoding human eosinophil differentiation factor (interleukin 5). Proc Natl
Acad Sci U S A 84: 6629-6633.
QUICK LINKS
- SUBMIT MANUSCRIPT
- RECOMMEND THE JOURNAL
-
SUBSCRIBE FOR ALERTS
RELATED JOURNALS
- Advance Research on Endocrinology and Metabolism (ISSN: 2689-8209)
- Journal of Allergy Research (ISSN:2642-326X)
- Journal of Ageing and Restorative Medicine (ISSN:2637-7403)
- Advance Research on Alzheimers and Parkinsons Disease
- International Journal of Diabetes (ISSN: 2644-3031)
- Archive of Obstetrics Gynecology and Reproductive Medicine (ISSN:2640-2297)
- Journal of Infectious Diseases and Research (ISSN: 2688-6537)